Integration of dual-energy CT parameters and radiomics features for non-invasive prediction of -SMA and CD8 + T cell in non-small cell lung cancer.
[BACKGROUND] The non-invasive characterization of the tumor microenvironment (TME) is essential for stratifying non-small cell lung cancer (NSCLC) patients who may benefit from immunotherapy.
APA
Jiang N, Zhang Y, et al. (2026). Integration of dual-energy CT parameters and radiomics features for non-invasive prediction of -SMA and CD8 + T cell in non-small cell lung cancer.. Frontiers in medicine, 13, 1792692. https://doi.org/10.3389/fmed.2026.1792692
MLA
Jiang N, et al.. "Integration of dual-energy CT parameters and radiomics features for non-invasive prediction of -SMA and CD8 + T cell in non-small cell lung cancer.." Frontiers in medicine, vol. 13, 2026, pp. 1792692.
PMID
41889495
Abstract
[BACKGROUND] The non-invasive characterization of the tumor microenvironment (TME) is essential for stratifying non-small cell lung cancer (NSCLC) patients who may benefit from immunotherapy. This study investigates a novel approach by integrating dual-energy CT (DECT) parameters with radiomics to quantitatively assess stromal fibrosis (via -SMA area) and CD8 + T-cell infiltration.
[METHODS] In this prospective study, 70 treatment-naive NSCLC patients were enrolled. Preoperative DECT scans were used to extract both DECT parameters and radiomics features. Corresponding surgical specimens were analyzed to determine the area percentage of -SMA-positive stroma and the density of CD8 + T cells, with patients classified into high and low groups for each biomarker. After feature selection, models were constructed based on DECT parameters alone, radiomics features alone, and a combined feature set. Models were evaluated via 5-fold cross-validation.
[RESULTS] For predicting high -SMA expression, the integrated model combining DECT parameters and radiomics features demonstrated superior performance (AUC: 0.766) compared to models using either modality alone (DECT AUC: 0.670; radiomics AUC: 0.703). In contrast, for predicting CD8 + T-cell density, the DECT-only model (AUC: 0.715) performed comparably to the radiomics model (AUC: 0.695), with no significant gain from integration. Key discriminating features, such as normalized iodine concentration for -SMA and spectral slope of K40-70 for CD8+, showed significant intergroup differences and plausible biological correlations.
[CONCLUSION] The integration of DECT and radiomics presents a feasible, non-invasive strategy to assess specific TME components in NSCLC, underscoring the complementary value of different imaging data types towards developing biomarkers for personalized oncology.
[METHODS] In this prospective study, 70 treatment-naive NSCLC patients were enrolled. Preoperative DECT scans were used to extract both DECT parameters and radiomics features. Corresponding surgical specimens were analyzed to determine the area percentage of -SMA-positive stroma and the density of CD8 + T cells, with patients classified into high and low groups for each biomarker. After feature selection, models were constructed based on DECT parameters alone, radiomics features alone, and a combined feature set. Models were evaluated via 5-fold cross-validation.
[RESULTS] For predicting high -SMA expression, the integrated model combining DECT parameters and radiomics features demonstrated superior performance (AUC: 0.766) compared to models using either modality alone (DECT AUC: 0.670; radiomics AUC: 0.703). In contrast, for predicting CD8 + T-cell density, the DECT-only model (AUC: 0.715) performed comparably to the radiomics model (AUC: 0.695), with no significant gain from integration. Key discriminating features, such as normalized iodine concentration for -SMA and spectral slope of K40-70 for CD8+, showed significant intergroup differences and plausible biological correlations.
[CONCLUSION] The integration of DECT and radiomics presents a feasible, non-invasive strategy to assess specific TME components in NSCLC, underscoring the complementary value of different imaging data types towards developing biomarkers for personalized oncology.
같은 제1저자의 인용 많은 논문 (5)
- Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study.
- RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment.
- Dual-targeted microspheres reshape the metabolic-immune microenvironment to reverse post-embolization dilemmas in hepatocellular carcinoma.
- ECN Coated with Met Can Inhibit PD-L1 Expression in Tumor Cells and Enhance Immune-Mediated Antitumor Effects in CT26 Cells.
- The promising arsenal of ferroptosis inducers in bladder cancer.